文献速递角膜与眼表疾病

原发病与角膜血管化对角膜移植排斥和存活的不同影响

Differential effects of primary disease and corneal vascularisation on corneal transplant rejection and survival.
PubMed 文献 · Br J Ophthalmol · 2019-08-28

基于英国移植登记库1999至2017年因圆锥角膜、假晶状体大疱性角膜病变或既往感染首次接受角膜移植的成人数据分析显示,角膜血管化是移植后5年内排斥的危险因素,但风险幅度因移植适应证而异,且血管化未与调整后移植失败风险增加相关。

要点

  • 圆锥角膜、假晶状体大疱性角膜病变和感染组术前角膜血管化记录比例分别为10%、25%和67%。
  • 假晶状体大疱性角膜病变患者血管化超过两个象限时排斥风险增加(HR 1.5,p=0.004)。
  • 既往感染患者四个象限血管化时排斥风险增加(HR 1.6,p=0.003),血管化未与任何组调整后移植失败风险增加相关。

核心结论

  • 血管化是角膜同种异体移植后5年内排斥的危险因素,移植适应证对风险幅度有临床显著影响。

研究设计与样本

  • 分析英国移植登记库中1999至2017年因圆锥角膜、假晶状体大疱性角膜病变或既往感染首次接受角膜移植的所有成人。
  • 采用多变量风险调整Cox回归模型分析排斥和移植失败的危险因素。

主要发现

  • 圆锥角膜、假晶状体大疱性角膜病变和感染组术前角膜血管化记录比例分别为10%、25%和67%。
  • 假晶状体大疱性角膜病变患者血管化超过两个象限时排斥风险增加(HR 1.5,p=0.004),浅层和/或深层血管化存在时排斥风险分别增加(HR 1.3和1.4,p=0.004)。
  • 既往感染患者四个象限血管化时排斥风险增加(HR 1.6,p=0.003)。
  • 任何组中血管化均未与调整后移植失败风险增加相关。
  • 在圆锥角膜和假晶状体大疱性角膜病变的血管化受体角膜中,板层移植相比穿透性移植降低排斥和/或失败风险有弱证据。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To investigate the relative risk of pretransplant corneal vascularisation on rate of rejection and graft failure within 5 years of surgery when categorised by indication for transplantation.We analysed all adults recorded in the UK transplant registry who had a first cornea transplant for keratoconus (KC), pseudophakic bullous keratopathy (PBK) or previous infection (viral/bacterial/fungal/protozoan) between 1999 and 2017. We analysed the number of quadrants of the recipient cornea vascularised before transplant and type of vascularisation, the interval post-transplant to rejection, if any, and the outcome at 5 years post-transplant. Risk factors for rejection and transplant failure were modelled by multivariable risk-adjusted Cox regression. RESULTS: Corneal vascularisation was recorded in 10%, 25% and 67% of patients with KC, PBK and infection, respectively. Individuals with PBK had an increased hazard of transplant rejection only when there were more than two quadrants of vascularisation (HR 1.5, p=0.004) when either superficial and/or deep vascularisation was present (HR 1.3 and 1.4, respectively, p=0.004). Individuals who had a transplant for previous infection had an increased hazard of rejection with four quadrants of vascularisation (HR 1.6, p=0.003). There was no risk-adjusted increase in transplant failure associated with vascularisation in any group. There was weak evidence of reduction in risk of rejection and/or failure associated with lamellar compared with penetrating transplantation in KC and PBK in vascularised recipient corneas. CONCLUSION: Vascularisation is a risk factor for corneal allograft rejection within 5 years. The indication for transplantation has a clinically significant effect on the magnitude of this risk.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Sibley D, Hopkinson CL, Tuft SJ, et al. Differential effects of primary disease and corneal vascularisation on corneal transplant rejection and survival. Br J Ophthalmol. 2019. PMID: 31462418. doi:10.1136/bjophthalmol-2019-314200

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。